Impact of Arsenic Trioxide on LS-174T Cell Growth in vitro and the Activity of Telomerase

被引:0
|
作者
WANG Xi-shan 1**
2. Department of Pharmacology
3. Department of Genetics
机构
关键词
Arsenic trioxide; Telomerase; Colorectal carcinoma; Apoptosis;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
The therapeutic action of arsenic trioxide(As 2O 3) on solid tumors has aroused widespread interest among scholars. To study the impact of As 2O 3 on human colorectal carcinoma cells(LS-174T cell) and the activity of telomerase, the methods of PCR-ELISA, flow cytometry(FCM) and MTT assay in vitro were utilized. The results show that (1) with an increase in the concentration of As 2O 3, the ratio of living the cells to dead cells decreases significantly, and the IC50 value is 5.23 μg/mL; (2) the cells of the experimental groups can endure a series of morphological changes similar to the features of apoptosis; (3) the apoptotic curves of FCM pictures appear after 24 h, and the cells show the apoptosis in a time-dependent manner; (4) As 2O 3 can inhibit the activity of telomerase of the cell extraction obviously in a concentration-dependent and time-dependent manner after 24 h. It can be concluded from the experiment results in vitro that As 2O 3 can induce the apoptosis of LS-174T cells and inhibit the telomerase activity. Therefore, it has been proposed, for the first time, that these two factors(the apoptosis of LS-174T cells and the inhibition to the telomerase activity) are important causes of the LS-174T cell death caused by As 2O 3.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 50 条
  • [21] In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia
    Récher, C
    Chopin, M
    Raffoux, E
    Pierron, G
    Poupon, J
    Sigaux, F
    Dombret, H
    Stern, MH
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 343 - 350
  • [22] Preliminary Study of the in vitro Growth Inhibition of Human Bladder Cancer Cell Line BIU-87 by Arsenic Trioxide
    童强松
    曾甫清
    朱朝晖
    鲁功成
    JournalofTongjiMedicalUniversity, 2000, (02) : 112 - 115
  • [23] Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (AS2O3) in endometrial carcinoma cells
    Zhou, Chunxiao
    Boggess, John F.
    Bae-Jump, Victoria
    Gehrig, Paola A.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 218 - 222
  • [24] Preliminary study of the in vitro growth inhibition of human bladder cancer cell line BIU-87 by arsenic trioxide
    Tong Qiangsong
    Zeng Fuqing
    Zhu Zhaohui
    Lu Gongcheng
    Current Medical Science, 2000, 20 (2) : 112 - 115
  • [25] Effect of arsenic trioxide on uveal melanoma cell proliferation in vitro
    Wang, Chunfang
    Li, Bin
    Zhang, Haiyan
    Li, Weihong
    Jonas, Jost B.
    OPHTHALMIC RESEARCH, 2007, 39 (06) : 302 - 307
  • [26] Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo
    Kuo, Yu-Jui
    Liu, Yan-Jin
    Way, Tzong-Der
    Chiang, Su-Yin
    Lin, Jaung-Geng
    Chung, Jing-Gung
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3388 - 3396
  • [27] Arsenic trioxide: impact on the growth and differentiation of cancer cells and possible use in cancer therapy
    Hoffman, Ewelina
    Mielicki, Wojciech P.
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2013, 67 : 817 - 827
  • [28] Gene expression profiling upon 212Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model
    Yong, Kwon J.
    Milenic, Diane E.
    Baidoo, Kwamena E.
    Kim, Young-Seung
    Brechbiel, Martin W.
    CANCER MEDICINE, 2013, 2 (05): : 646 - 653
  • [29] Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro
    Guo, JM
    Kang, GZ
    Xiao, BX
    Liu, DH
    Zhang, S
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (05) : 882 - 888
  • [30] Tumour growth-suppressive effect of arsenic trioxide in squamous cell lung carcinoma
    Leung, Leanne Lee
    Lam, Sze-Kwan
    Li, Yuan-Yuan
    Ho, James Chung-Man
    ONCOLOGY LETTERS, 2017, 14 (03) : 3748 - 3754